Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Maslak

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Blood|December 7, 2007
Myelodysplastic syndrome associated with isolated del (5q) chromosome abnormality ("5q- syndrome")Peter Maslak
Blood|September 7, 2006
AcanthocytesPeter Maslak
Current Hematology Reports|August 7, 2003
Clinical applications of molecular monitoring in leukemiaPeter Maslak
Blood|February 5, 2003
Mast cell leukemiaPeter Maslak
Expert Opinion on Pharmacotherapy|July 17, 2008
Azacitidine and the beginnings of therapeutic epigenetic modulationKristen O'Dwyer, Peter Maslak
Blood|May 10, 2007
HistoplasmosisPeter Maslak, Lisa Southern
Advances in Pharmacology (San Diego, Calif.)|October 7, 2004
Therapy of acute promyelocytic leukemiaSteven Soignet, Peter Maslak
Blood|December 12, 2003
Chronic myelomonocytic leukemiaPeter Maslak, Susan McKenzie
Nature Clinical Practice. Oncology|May 10, 2006
Antibody-drug conjugates in acute myeloid leukemiaDavid A Scheinberg, Joseph G Jurcic, Peter Maslak
American Journal of Clinical Pathology|September 21, 2014
Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancerEllinor I B Peerschke, Melissa S Pessin, Peter Maslak
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Blood|December 7, 2007
Myelodysplastic syndrome associated with isolated del (5q) chromosome abnormality ("5q- syndrome")Peter Maslak
Blood|September 7, 2006
AcanthocytesPeter Maslak
Current Hematology Reports|August 7, 2003
Clinical applications of molecular monitoring in leukemiaPeter Maslak
Blood|February 5, 2003
Mast cell leukemiaPeter Maslak
Expert Opinion on Pharmacotherapy|July 17, 2008
Azacitidine and the beginnings of therapeutic epigenetic modulationKristen O'Dwyer, Peter Maslak
Blood|May 10, 2007
HistoplasmosisPeter Maslak, Lisa Southern
Advances in Pharmacology (San Diego, Calif.)|October 7, 2004
Therapy of acute promyelocytic leukemiaSteven Soignet, Peter Maslak
Blood|December 12, 2003
Chronic myelomonocytic leukemiaPeter Maslak, Susan McKenzie
Nature Clinical Practice. Oncology|May 10, 2006
Antibody-drug conjugates in acute myeloid leukemiaDavid A Scheinberg, Joseph G Jurcic, Peter Maslak
American Journal of Clinical Pathology|September 21, 2014
Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancerEllinor I B Peerschke, Melissa S Pessin, Peter Maslak
Pageof 5